Abstract
An important route for the management of various drugs is the lung drug delivery system (PDDS). In recent years, the lungs have become increasingly concerned about the scientific and environmental value of treating lung diseases. Lung delivery of drugs has evolved into one of the most widely used routes of the planned or local drug rescuer Due to its potential localized lung function; drug delivery systems for the treatment of lung diseases are being developed. In this article, it is pointed out that PDSDS provides improved compliance with appropriate patient outcomes. In the traditional form, this novel drug delivery system has several advantages. Because of its potential therapeutic properties in the field of pulmonary embolism, the use of drug delivery systems (DDS) in the treatment of lung diseases is growing. This route also facilitates the placement of drugs in high-intensity areas within the patient-specific lungs, thereby reducing the total amount of medication administered to patients (10-20% of the peroral volume), and increasing local drug activity while minimizing side effects and systemic side effects and bypass the first-pass metabolism.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
